Acer Therapeutics Analysis
| ACERDelisted Stock | USD 0.84 0.02 2.33% |
Acer Therapeutics is overvalued with Real Value of 0.73 and Hype Value of 0.84. The main objective of Acer Therapeutics delisted stock analysis is to determine its intrinsic value, which is an estimate of what Acer Therapeutics is worth, separate from its market price. There are two main types of Acer Therapeutics' stock analysis: fundamental analysis and technical analysis.
The Acer Therapeutics stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Acer Therapeutics is usually not traded on Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day. Acer Stock trading window is adjusted to America/New York timezone.
Acer |
Acer Stock Analysis Notes
About 14.0% of the company shares are held by company insiders. The company recorded a loss per share of 1.98. Acer Therapeutics last dividend was issued on the 21st of September 2017. The entity had 96:1000 split on the 21st of September 2017. Acer Therapeutics Inc., a pharmaceutical company, focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. Acer Therapeutics Inc. was incorporated in 1991 and is headquartered in Newton, Massachusetts. Acer Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 41 people. For more info on Acer Therapeutics please contact Christopher Schelling at 844 902 6100 or go to https://www.acertx.com.Acer Therapeutics Investment Alerts
| Acer Therapeutics is not yet fully synchronised with the market data | |
| Acer Therapeutics has some characteristics of a very speculative penny stock | |
| Acer Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| Acer Therapeutics currently holds 11.86 M in liabilities with Debt to Equity (D/E) ratio of 0.08, which may suggest the company is not taking enough advantage from borrowing. Acer Therapeutics has a current ratio of 0.85, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Acer Therapeutics' use of debt, we should always consider it together with its cash and equity. | |
| Net Loss for the year was (26.24 M) with profit before overhead, payroll, taxes, and interest of 1.26 M. | |
| Acer Therapeutics currently holds about 14.47 M in cash with (30.25 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.91, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 14.0% of Acer Therapeutics shares are held by company insiders |
Acer Therapeutics Upcoming and Recent Events
| 13th of November 2023 Upcoming Quarterly Report | View | |
| 25th of March 2024 Next Financial Report | View | |
| 30th of September 2023 Next Fiscal Quarter End | View | |
| 25th of March 2024 Next Fiscal Year End | View | |
| 30th of June 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Acer Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 22.02 M.Acer Therapeutics Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Acer Therapeutics insiders, such as employees or executives, is commonly permitted as long as it does not rely on Acer Therapeutics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Acer Therapeutics insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Seaman Scott B over a year ago Acquisition by Seaman Scott B of 17143 shares of Acer Therapeutics subject to Rule 16b-3 |
Acer Therapeutics Outstanding Bonds
Acer Therapeutics issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Acer Therapeutics uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Acer bonds can be classified according to their maturity, which is the date when Acer Therapeutics has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| ACE INA HLDGS Corp BondUS00440EAH09 | View | |
| ACE INA HLDGS Corp BondUS00440EAQ08 | View | |
| Dana 575 percent Corp BondUS235822AB96 | View | |
| ACE INA HLDGS Corp BondUS00440EAW75 | View | |
| ACE INA HLDGS Corp BondUS00440EAV92 | View | |
| ACE INA HLDGS Corp BondUS00440EAS63 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View |
Acer Therapeutics Predictive Daily Indicators
Acer Therapeutics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Acer Therapeutics stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
About Acer Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Acer Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Acer shares will generate the highest return on investment. We also built our delisted stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Delisted Stock such as Acer Therapeutics. By using and applying Acer Stock analysis, traders can create a robust methodology for identifying Acer entry and exit points for their positions.
Acer Therapeutics Inc., a pharmaceutical company, focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. Acer Therapeutics Inc. was incorporated in 1991 and is headquartered in Newton, Massachusetts. Acer Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 41 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Acer Therapeutics to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Portfolio Analyzer Now
Portfolio AnalyzerPortfolio analysis module that provides access to portfolio diagnostics and optimization engine |
| All Next | Launch Module |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Consideration for investing in Acer Stock
If you are still planning to invest in Acer Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Acer Therapeutics' history and understand the potential risks before investing.
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |